Cargando…

Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients

OBJECTIVE: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is the most common periodic fever syndrome in children; by definition, episodes occur every 2 to 8 weeks. However, in a subset of our patients, we noticed a higher frequency of attacks, of less than 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Broide, Mor, Levinsky, Yoel, Tal, Rotem, Harel, Liora, Shoham, Shoval, Ahmad, Sabreen Abu, Butbul Aviel, Yonatan, Amarilyo, Gil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474755/
https://www.ncbi.nlm.nih.gov/pubmed/37658370
http://dx.doi.org/10.1186/s12969-023-00880-1
_version_ 1785100571210940416
author Broide, Mor
Levinsky, Yoel
Tal, Rotem
Harel, Liora
Shoham, Shoval
Ahmad, Sabreen Abu
Butbul Aviel, Yonatan
Amarilyo, Gil
author_facet Broide, Mor
Levinsky, Yoel
Tal, Rotem
Harel, Liora
Shoham, Shoval
Ahmad, Sabreen Abu
Butbul Aviel, Yonatan
Amarilyo, Gil
author_sort Broide, Mor
collection PubMed
description OBJECTIVE: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is the most common periodic fever syndrome in children; by definition, episodes occur every 2 to 8 weeks. However, in a subset of our patients, we noticed a higher frequency of attacks, of less than 2 weeks, which we refer to as extreme PFAPA (ePFAPA). This group consisted of patients who were extreme upon presentation of PFAPA, and those who became extreme after initiation of abortive corticosteroid treatment. We aimed to characterize demographic and clinical features of ePFAPA, including the two groups, and to compare them to patients with non-extreme PFAPA (nPFAPA). STUDY DESIGN: : The medical records of 365 patients with PFAPA who attended Schneider Children’s Medical Center of Israel from March 2014 to April 2021 were reviewed. Patients with concomitant familial Mediterranean fever were excluded. Characteristics of the ePFAPA (including subgroups) and nPFAPA groups were compared using Wilcoxon rank sum, Pearson’s chi-squared, and Fisher’s exact tests. RESULTS: Forty-seven patients (12.9%) were identified as having ePFAPA. Among patients with ePFAPA, compared to patients with nPFAPA, the median (interquartile range) age at disease onset was earlier: 1.5 years (0.7–2.5) vs. 2.5 years (1.5-4.0), P < 0.001; and diagnosis was younger: 2.6 years (2.0-3.6) vs. 4.5 years (3.0-6.2), P < 0.001. A higher proportion of patients with ePFAPA than nPFAPA were treated with colchicine prophylaxis (53% vs. 19%, P < 0.001), but symptoms and signs during flares did not differ significantly between these groups. Demographic and clinical characteristics were similar between patients with ePFAPA from presentation of PFAPA (22, 47% of those with ePFAPA) and ePFAPA from after corticosteroid treatment. CONCLUSION: About half the patients categorized with ePFAPA syndrome already had extreme features upon presentation. Patients with ePFAPA compared to nPFAPA presented and were diagnosed at an earlier age. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12969-023-00880-1.
format Online
Article
Text
id pubmed-10474755
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104747552023-09-03 Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients Broide, Mor Levinsky, Yoel Tal, Rotem Harel, Liora Shoham, Shoval Ahmad, Sabreen Abu Butbul Aviel, Yonatan Amarilyo, Gil Pediatr Rheumatol Online J Research Article OBJECTIVE: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is the most common periodic fever syndrome in children; by definition, episodes occur every 2 to 8 weeks. However, in a subset of our patients, we noticed a higher frequency of attacks, of less than 2 weeks, which we refer to as extreme PFAPA (ePFAPA). This group consisted of patients who were extreme upon presentation of PFAPA, and those who became extreme after initiation of abortive corticosteroid treatment. We aimed to characterize demographic and clinical features of ePFAPA, including the two groups, and to compare them to patients with non-extreme PFAPA (nPFAPA). STUDY DESIGN: : The medical records of 365 patients with PFAPA who attended Schneider Children’s Medical Center of Israel from March 2014 to April 2021 were reviewed. Patients with concomitant familial Mediterranean fever were excluded. Characteristics of the ePFAPA (including subgroups) and nPFAPA groups were compared using Wilcoxon rank sum, Pearson’s chi-squared, and Fisher’s exact tests. RESULTS: Forty-seven patients (12.9%) were identified as having ePFAPA. Among patients with ePFAPA, compared to patients with nPFAPA, the median (interquartile range) age at disease onset was earlier: 1.5 years (0.7–2.5) vs. 2.5 years (1.5-4.0), P < 0.001; and diagnosis was younger: 2.6 years (2.0-3.6) vs. 4.5 years (3.0-6.2), P < 0.001. A higher proportion of patients with ePFAPA than nPFAPA were treated with colchicine prophylaxis (53% vs. 19%, P < 0.001), but symptoms and signs during flares did not differ significantly between these groups. Demographic and clinical characteristics were similar between patients with ePFAPA from presentation of PFAPA (22, 47% of those with ePFAPA) and ePFAPA from after corticosteroid treatment. CONCLUSION: About half the patients categorized with ePFAPA syndrome already had extreme features upon presentation. Patients with ePFAPA compared to nPFAPA presented and were diagnosed at an earlier age. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12969-023-00880-1. BioMed Central 2023-09-01 /pmc/articles/PMC10474755/ /pubmed/37658370 http://dx.doi.org/10.1186/s12969-023-00880-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Broide, Mor
Levinsky, Yoel
Tal, Rotem
Harel, Liora
Shoham, Shoval
Ahmad, Sabreen Abu
Butbul Aviel, Yonatan
Amarilyo, Gil
Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients
title Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients
title_full Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients
title_fullStr Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients
title_full_unstemmed Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients
title_short Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients
title_sort extreme periodic fever, aphthous stomatitis, pharyngitis, adenitis (pfapa): a discrete group of patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474755/
https://www.ncbi.nlm.nih.gov/pubmed/37658370
http://dx.doi.org/10.1186/s12969-023-00880-1
work_keys_str_mv AT broidemor extremeperiodicfeveraphthousstomatitispharyngitisadenitispfapaadiscretegroupofpatients
AT levinskyyoel extremeperiodicfeveraphthousstomatitispharyngitisadenitispfapaadiscretegroupofpatients
AT talrotem extremeperiodicfeveraphthousstomatitispharyngitisadenitispfapaadiscretegroupofpatients
AT harelliora extremeperiodicfeveraphthousstomatitispharyngitisadenitispfapaadiscretegroupofpatients
AT shohamshoval extremeperiodicfeveraphthousstomatitispharyngitisadenitispfapaadiscretegroupofpatients
AT ahmadsabreenabu extremeperiodicfeveraphthousstomatitispharyngitisadenitispfapaadiscretegroupofpatients
AT butbulavielyonatan extremeperiodicfeveraphthousstomatitispharyngitisadenitispfapaadiscretegroupofpatients
AT amarilyogil extremeperiodicfeveraphthousstomatitispharyngitisadenitispfapaadiscretegroupofpatients